Effectiveness of LASER Therapy and PNF Technique in Neck Pain (NCT07566637) | Clinical Trial Compass
CompletedNot Applicable
Effectiveness of LASER Therapy and PNF Technique in Neck Pain
Turkey (Türkiye)75 participantsStarted 2024-02-05
Plain-language summary
This study aimed to investigate and compare the effects of low-intensity laser therapy, a photobiomodulation treatment, and proprioceptive neuromuscular facilitation on pain and disability in individuals with non-specific neck pain. This randomized controlled trial used the Numerical Pain Scale (primary outcome) and the Bournemouth Neck Pain Questionnaire to assess pain, a manual algometer to assess pain threshold, and the Neck Disability Index to assess disability. Three groups were included in this randomized controlled trial: Group 1: Photobiomodulation therapy (low-intensity laser therapy) + conventional physiotherapy; Group 2: Proprioceptive neuromuscular facilitation with stretching and strengthening + conventional physiotherapy; Group 3: Conventional physiotherapy only. We hypothesized that low-intensity laser therapy and proprioceptive neuromuscular facilitation would have distinct effects on pain and disability in chronic non-specific neck pain.
Who can participate
Age range
18 Years – 65 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Volunteering to participate in the study
* A neck pain score of at least 3 on the Numerical Pain Scale in the assessment conducted prior to inclusion in the study
* A Neck Disability Index score of 5 or higher
* No comorbid conditions affecting the orthopaedic, neurological or cardiopulmonary systems
* Participants who have not been enrolled in another clinical trial within the last month
Exclusion Criteria:
* Individuals who have undergone upper limb surgery (e.g. shoulder blade, shoulder, elbow, hand, wrist, etc.) within the last year
* Individuals with a pacemaker or subcutaneous implant
* Pregnant women or women who have recently given birth
* Use of antidepressants, anti-inflammatory drugs or anxiolytics within the last 6 months
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.